Global Oligonucleotide Synthesis Market Analysis 2024 – Estimated Market Size And Key Drivers

The Oligonucleotide Synthesis Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Oligonucleotide Synthesis Market:
https://www.thebusinessresearchcompany.com/report/oligonucleotide-synthesis-global-market-report

According to The Business Research Company’s Oligonucleotide Synthesis Global Market Report 2024, The oligonucleotide synthesis market size has grown rapidly in recent years. It will grow from $8.85 billion in 2023 to $10.27 billion in 2024 at a compound annual growth rate (CAGR) of 16.0%.  The  growth in the historic period can be attributed to growth in biomedical research advancements, therapeutic development, biotechnology innovations, genomic studies, increasing dna technologies.

The oligonucleotide synthesis market size is expected to see rapid growth in the next few years. It will grow to $18.67 billion in 2028 at a compound annual growth rate (CAGR) of 16.1%.  The growth in the forecast period can be attributed to emerging diagnostic tools, rna interference (rnai) therapies, regenerative medicine, nanotechnology applications, advancements in gene editing. Major trends in the forecast period include targeted drug development, innovative delivery systems, automated synthesis, crispr-cas technology, next-generation sequencing (ngs).

The rising prevalence of chronic diseases is expected to propel the growth of the oligonucleotide synthesis market going forward. Chronic diseases refer to conditions that last one year or longer and require continuous medical attention, which may worsen over time. Oligonucleotides, via various mechanisms, act on gene expression that causes chronic diseases. They can target mRNA, pre-mRNA, or non-coding RNA to modulate splicing events, induce degradation, or interfere with protein translation. For instance, in January 2022, according to the International Diabetes Federation, a Belgium-based organization of national diabetes associations, the global diabetes prevalence in 20–79-year-olds was 536.6 million in 2021 and is expected to increase by 12.2% in 2045. Furthermore, in September 2022, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, there were 41 million deaths, which is 74% of those caused by non-communicable diseases (NCDs) or chronic diseases every year globally. There were 17.9 million deaths from cardiovascular diseases, 9.3 million deaths from cancer, 4.1 million deaths from chronic respiratory diseases, and 2.0 million deaths from diabetes. Therefore, the rising prevalence of chronic and rare diseases is driving the growth of the oligonucleotide synthesis market.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=12176&type=smp

The oligonucleotide synthesis market covered in this report is segmented –

1) By Type: Custom Oligos, Predesigned Oligos
2) By Product Type: Oligonucleotides, Reagents, Equipment, Services, Purification, Modification
3) By Application: Therapeutic Applications, Research Applications, Diagnostic Applications

Product innovation is the key trend gaining popularity in the oligonucleotide synthesis market. Major companies operating in the oligonucleotide synthesis market are developing innovative products to sustain their position in the market. For instance, in July 2021, DNA Script, a France-based DNA synthesis company, launched Syntax, a benchtop DNA printer designed for molecular biology and genomics applications. The printer enables the on-site synthesis of DNA oligonucleotides (oligos) for genomics workflow. Syntax, powered by the enzymatic DNA synthesis (EDS) technology of DNA Script, is the company’s first tabletop nucleic acid printer. The Syntax system has a desktop DNA printer, consumables and reagent kits, and management software. The Syntax takes less than 15 minutes to set up and can synthesize 20 meters in as little as six hours and as many as 60 meters in as little as 13 hours. The printer then purifies, quantifies, and normalizes the oligos when synthesis is finished so they can be used in the following stage of the research procedure.

The oligonucleotide synthesis market report table of contents includes:

1. Executive Summary
2. Market Characteristics
3. Market Trends And Strategies
4. Impact Of COVID-19
5. Market Size And Growth
6. Segmentation
7. Regional And Country Analysis
.
.
.
27. Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model